RASSF1 and cancer: The DNA methyltransferase (DNMT) inhibitor zebularine has been used to effectively reexpress RASSF1A and show an increase in cancer cell sensitivity to radiation-induced damage in vitro and in vivo [101] as well as to cisplatin [32].